By Stephen Sullivan, Managing Editor
Today’s issue of WorkCompRecap features the release of a new report from CWCI that found since California implemented its workers’ comp formulary last year, an increased share of drugs prescribed are either “Exempt” from prospective UR or “Not Listed” in the formulary, while the share of “Non-Exempt” drugs, which require UR, declined.
The report compares first half data from 2018 to the same ‘pre-formulary’ periods in 2017 and 2016, with Non-Exempt drugs falling to 45.1% of scripts, from 54.3% and 52.9% in the pre-formulary periods. The report also notes that the mix of drug payments also changed, as Exempt drugs declined from ~22% of payments to ~19%; Non-Exempt drugs fell from more than half of payments to 42%; and Not Listed drugs increased from about a quarter of total drug spend to nearly 39%.
Find out more (including a link to the free report!) by clicking here!